MYSODELLE Vaginal delivery system Ref.[7775] Active ingredients: Misoprostol

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2017  Publisher: Ferring Pharmaceuticals Ltd, Drayton Hall, Church Road, West Drayton, UB7 7PS, (UK)

Product name and form

Mysodelle 200 micrograms vaginal delivery system.

Pharmaceutical Form

Vaginal delivery system.

The polymer insert is contained within a retrieval system consisting of an inert woven polyester pouch and tail. The polymer insert is rectangular in shape with radiused corners, is buff coloured, semi-transparent, non-biodegradable and measures approximately 30 mm in length, 10 mm in width and 0.8 mm in thickness. Mysodelle swells in the presence of moisture.

Qualitative and quantitative composition

Mysodelle contains 200 micrograms misoprostol.

Misoprostol is released in vivo at a mean rate of approximately 7 micrograms/hour over a period of 24 hours. Drug release continues as long as Mysodelle is in the vagina.

Excipients with known effect: 0.13 mg butylated hydroxyanisole per dose (see Section 4.4).

For the full list of excipients, see Section 6.1.

Active Ingredient Description
Misoprostol

Misoprostol is an analogue of naturally occurring prostaglandin E1 which promotes peptic ulcer healing and symptomatic relief. Misoprostol protects the gastroduodenal mucosa by inhibiting basal, stimulated and nocturnal acid secretion and by reducing the volume of gastric secretions, the proteolytic activity of the gastric fluid, and increasing bicarbonate and mucus secretion.

List of Excipients

Cross-linked hydrogel polymer (comprised of macrogol, 1,2,6- hexanetriol and dicyclohexyl-methane-4,4'-diisocyanate).
Butylated Hydroxyanisole
Polyester retrieval system (knitted polyester yarn)

Pack sizes and marketing

1 × 200 micrograms vaginal delivery system
5 × 200 micrograms vaginal delivery system
5 × 200 micrograms vaginal delivery system (multipack)

Each vaginal delivery system is contained within an individual foil sachet produced from an aluminium foil laminate strip containing a desiccant and packed in a carton.

Not all pack sizes may be marketed.

Marketing authorization holder

Ferring Pharmaceuticals Ltd, Drayton Hall, Church Road, West Drayton, UB7 7PS, (UK)

Marketing authorization dates and numbers

PL 03194/0112

17th October 2013

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.